TMCnet

Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI

The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is entering a stable growth phase, driven by rising hospital demand for faster imaging workflows, AI-powered ...
Neurology Advisor

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
MobiHealthNews

Springbok Analytics receives FDA 510(k) clearance for MuscleView

Springbok Analytics, a life sciences muscle and analytics company, has received FDA 510(k) clearance for MuscleView, an AI-powered technology that analyzes muscle health via magnetic resonance (MR) ...
ascopubs.org

Histopathology-verified comparison of FET PET and contrast-enhanced MRI for tumor visualization in glioblastoma.

Interrupting HEG1/Cx43 interaction to promote cuproptosis via inhibiting gap junction to overcome glioblastoma radioresistance. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I.
Healio

FDA approves Ambelvist MRI contrast agent with lower dose of gadolinium

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...

Future Market Insights: Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI

The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is entering a stable growth phase, driven by rising hospital ...